Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy

Abstract Background Several studies have suggested that lung tissue heterogeneity is associated with overall survival (OS) in lung cancer. However, the quantitative relationship between the two remains unknown. The purpose of this study is to investigate the prognostic value of whole lung-based and...

Full description

Saved in:
Bibliographic Details
Main Authors: Meng Yan, Zhen Zhang, Jia Tian, Jiaqi Yu, Andre Dekker, Dirk de Ruysscher, Leonard Wee, Lujun Zhao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Radiation Oncology
Subjects:
Online Access:https://doi.org/10.1186/s13014-025-02583-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594562069037056
author Meng Yan
Zhen Zhang
Jia Tian
Jiaqi Yu
Andre Dekker
Dirk de Ruysscher
Leonard Wee
Lujun Zhao
author_facet Meng Yan
Zhen Zhang
Jia Tian
Jiaqi Yu
Andre Dekker
Dirk de Ruysscher
Leonard Wee
Lujun Zhao
author_sort Meng Yan
collection DOAJ
description Abstract Background Several studies have suggested that lung tissue heterogeneity is associated with overall survival (OS) in lung cancer. However, the quantitative relationship between the two remains unknown. The purpose of this study is to investigate the prognostic value of whole lung-based and tumor-based radiomics for OS in LA-NSCLC treated with definitive radiotherapy. Methods A total of 661 patients with LA-NSCLC treated with definitive radiotherapy in combination with chemotherapy were enrolled in this study, with 292 patients in the training set, 57 patients from the same hospital from January to December 2017 as an independent test set (test-set-1), 83 patients from a multi-institutional prospective clinical trial data set (RTOG0617) as test-set-2, and 229 patients from a Dutch radiotherapy center as test-set-3. Tumor-based radiomic features and whole lung-based radiomic features were extracted from primary tumor and whole lungs (excluding the primary tumor) delineations in planning CT images. Feature selection of radiomic features was done by the least absolute shrinkage (LASSO) method embedded with a Cox proportional hazards (CPH) model with 5-fold cross-internal validation, with 1000 bootstrap samples. Radiomics prognostic scores (RS) were calculated by CPH regression based on selected features. Three models based on a tumor RS, and a lung RS separately and their combinations were constructed. The Harrell concordance index (C-index) and calibration curves were used to evaluate the discrimination and calibration performance. Patients were stratified into high and low risk groups based on median RS, and a log-rank test was performed. Results The discrimination ability of lung- and tumor-based radiomics model was similar in terms of C-index, 0.69 vs. 0.68 in training set, 0.68 vs. 0.66 in test-set-1, 0.61 vs. 0.62 in test-set-2, 0.65 vs. 0.64 in test-set-3. The combination of tumor- and lung-based radiomics model performed best, with C-index of 0.71 in training set, 0.70 in test-set-1, 0.69 in test-set-2, and 0.68 in test-set-3. The calibration curve showed good agreement between predicted values and actual values. Patients were well stratified in training set, test-set-1 and test-set-3. In test-set-2, it was only whole lung-based RS that could stratify patients well and tumor-based RS performed bad. Conclusion Lung- and tumor-based radiomic features have the power to predict OS in LA-NSCLC. The combination of tumor- and lung-based radiomic features can achieve optimal performance.
format Article
id doaj-art-9e226ef9c76a4221a6c443c3dc35369a
institution Kabale University
issn 1748-717X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Radiation Oncology
spelling doaj-art-9e226ef9c76a4221a6c443c3dc35369a2025-01-19T12:33:54ZengBMCRadiation Oncology1748-717X2025-01-012011910.1186/s13014-025-02583-1Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapyMeng Yan0Zhen Zhang1Jia Tian2Jiaqi Yu3Andre Dekker4Dirk de Ruysscher5Leonard Wee6Lujun Zhao7Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for CancerZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of SciencesDepartment of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for CancerDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for CancerAbstract Background Several studies have suggested that lung tissue heterogeneity is associated with overall survival (OS) in lung cancer. However, the quantitative relationship between the two remains unknown. The purpose of this study is to investigate the prognostic value of whole lung-based and tumor-based radiomics for OS in LA-NSCLC treated with definitive radiotherapy. Methods A total of 661 patients with LA-NSCLC treated with definitive radiotherapy in combination with chemotherapy were enrolled in this study, with 292 patients in the training set, 57 patients from the same hospital from January to December 2017 as an independent test set (test-set-1), 83 patients from a multi-institutional prospective clinical trial data set (RTOG0617) as test-set-2, and 229 patients from a Dutch radiotherapy center as test-set-3. Tumor-based radiomic features and whole lung-based radiomic features were extracted from primary tumor and whole lungs (excluding the primary tumor) delineations in planning CT images. Feature selection of radiomic features was done by the least absolute shrinkage (LASSO) method embedded with a Cox proportional hazards (CPH) model with 5-fold cross-internal validation, with 1000 bootstrap samples. Radiomics prognostic scores (RS) were calculated by CPH regression based on selected features. Three models based on a tumor RS, and a lung RS separately and their combinations were constructed. The Harrell concordance index (C-index) and calibration curves were used to evaluate the discrimination and calibration performance. Patients were stratified into high and low risk groups based on median RS, and a log-rank test was performed. Results The discrimination ability of lung- and tumor-based radiomics model was similar in terms of C-index, 0.69 vs. 0.68 in training set, 0.68 vs. 0.66 in test-set-1, 0.61 vs. 0.62 in test-set-2, 0.65 vs. 0.64 in test-set-3. The combination of tumor- and lung-based radiomics model performed best, with C-index of 0.71 in training set, 0.70 in test-set-1, 0.69 in test-set-2, and 0.68 in test-set-3. The calibration curve showed good agreement between predicted values and actual values. Patients were well stratified in training set, test-set-1 and test-set-3. In test-set-2, it was only whole lung-based RS that could stratify patients well and tumor-based RS performed bad. Conclusion Lung- and tumor-based radiomic features have the power to predict OS in LA-NSCLC. The combination of tumor- and lung-based radiomic features can achieve optimal performance.https://doi.org/10.1186/s13014-025-02583-1RadiomicsRadiotherapyLung cancerOverall survival
spellingShingle Meng Yan
Zhen Zhang
Jia Tian
Jiaqi Yu
Andre Dekker
Dirk de Ruysscher
Leonard Wee
Lujun Zhao
Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
Radiation Oncology
Radiomics
Radiotherapy
Lung cancer
Overall survival
title Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
title_full Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
title_fullStr Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
title_full_unstemmed Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
title_short Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
title_sort whole lung radiomic features are associated with overall survival in patients with locally advanced non small cell lung cancer treated with definitive radiotherapy
topic Radiomics
Radiotherapy
Lung cancer
Overall survival
url https://doi.org/10.1186/s13014-025-02583-1
work_keys_str_mv AT mengyan wholelungradiomicfeaturesareassociatedwithoverallsurvivalinpatientswithlocallyadvancednonsmallcelllungcancertreatedwithdefinitiveradiotherapy
AT zhenzhang wholelungradiomicfeaturesareassociatedwithoverallsurvivalinpatientswithlocallyadvancednonsmallcelllungcancertreatedwithdefinitiveradiotherapy
AT jiatian wholelungradiomicfeaturesareassociatedwithoverallsurvivalinpatientswithlocallyadvancednonsmallcelllungcancertreatedwithdefinitiveradiotherapy
AT jiaqiyu wholelungradiomicfeaturesareassociatedwithoverallsurvivalinpatientswithlocallyadvancednonsmallcelllungcancertreatedwithdefinitiveradiotherapy
AT andredekker wholelungradiomicfeaturesareassociatedwithoverallsurvivalinpatientswithlocallyadvancednonsmallcelllungcancertreatedwithdefinitiveradiotherapy
AT dirkderuysscher wholelungradiomicfeaturesareassociatedwithoverallsurvivalinpatientswithlocallyadvancednonsmallcelllungcancertreatedwithdefinitiveradiotherapy
AT leonardwee wholelungradiomicfeaturesareassociatedwithoverallsurvivalinpatientswithlocallyadvancednonsmallcelllungcancertreatedwithdefinitiveradiotherapy
AT lujunzhao wholelungradiomicfeaturesareassociatedwithoverallsurvivalinpatientswithlocallyadvancednonsmallcelllungcancertreatedwithdefinitiveradiotherapy